The publication of Ben Goldacre’s new book, Bad Pharma, which strongly criticizes the pharmaceutical industry appears to have the Association of the British Pharmaceutical Industry (ABPI) on the defensive. Following an article on Bad Pharma in the New Statesman by Helen Lewis the ABPI responded with a letter arguing some of the points made in the article.
Dr Goldacre has responded to this letter with a letter of his own reinforcing some of the claims made in the book and accusing ABPI’s CEO, Stephen Whitehead of making false claims in his attempt to defend the
I am currently about halfway through reading Bad Pharma myself and it is certainly a very revealing book. It will be interesting to see if the pharmaceutical continues to defend itself against Goldacre’s claim which are substantial and severe.